Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Cash (2016 - 2025)

Historic Change in Cash for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to -$50.6 million.

  • Macrogenics' Change in Cash fell 15283.25% to -$50.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.5 million, marking a year-over-year decrease of 21088.75%. This contributed to the annual value of $81.9 million for FY2024, which is 113284.56% up from last year.
  • Per Macrogenics' latest filing, its Change in Cash stood at -$50.6 million for Q3 2025, which was down 15283.25% from -$14.9 million recorded in Q2 2025.
  • Macrogenics' Change in Cash's 5-year high stood at $115.4 million during Q1 2023, with a 5-year trough of -$115.5 million in Q2 2023.
  • For the 5-year period, Macrogenics' Change in Cash averaged around -$5.3 million, with its median value being -$14.9 million (2025).
  • Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 390538.12% in 2022, then plummeted by 51610.29% in 2025.
  • Over the past 5 years, Macrogenics' Change in Cash (Quarter) stood at -$67.1 million in 2021, then soared by 137.12% to $24.9 million in 2022, then tumbled by 55.57% to $11.1 million in 2023, then tumbled by 70.93% to $3.2 million in 2024, then plummeted by 1672.53% to -$50.6 million in 2025.
  • Its Change in Cash was -$50.6 million in Q3 2025, compared to -$14.9 million in Q2 2025 and -$37.3 million in Q1 2025.